R. Scott Raynovich

The recent gold decline was certainly enormous. But the bigger question is whether the great gold bull market of the last decade is over, and I think the case is still open.

I've held large positions in gold and been a supporter of the gold bull market since about 2004. This comes with definite downside, the largest being that during gold's spectacular market declines, I become associated with gold bugs and vilifed like a doping contender on the Tour de France.

But in all my years of trading and watching gold, I've never seen anything like what's gone down this
past month.

On April 12, 2013, gold, which had been trading heavy over a number of months, suddenly went into freefall. Most reliable accounts indicate that a large seller of gold futures positions had opened the New York market by offering to sell about 30,000 futures contracts -- a mere 3 million ounces. This is several times what typically changes hand an entire day of trading. Because the gold market is quite small (relative to stocks or bonds) and not always the most liquid market, gold immediately plunged $50. And the seller kept selling.

In fact, by some counts, between Friday, April 12 and Monday, April 15, sellings of gold derivatives
contracts accounted for the equivalent of more than 100% of the world annual gold production -- and
this amount was sold on the market during just two days two days. Gold fell nearly $200 in that period.

And then there's this: This past week, Zero Hedge, analyzing the public documents of the major futures gold depositories, saying  that JP Morgan was responsible for selling 99% of the gold in the last three months. 

JP Morgan is a well-known metals broker or "bullion bank" and an agent of the precious metals acocunt of the Federal Reserve. So naturally, this leads you to the conspiracy theories.

I won't get into the conspiracy theories, but I will ask two simple questions: Why would somebody be
calling in massive amounts of gold from the depositories at the COMEX during the market's biggest
decline in years? Would "smart money" be laying claim to millions of dollars in physical gold if they thought the market was going to decline further?

As I mentioned, there are currently many paradoxes in the market. But this may be the largest. Why
are physical inventories of COMEX gold plummeting? Econ 101 tells you that plunging prices should be associated with large jumps in inventory, not declines.

The bottom line: It's too early to end to declare an end to this majestic bull market in gold, which started in 2002 and has represented a more than 500% return on the price through the era of Quantitative Everything (QE). The main reason: Physical demand for gold remains strong, despite the bizarre activity being generated by the futures market. And with the strange activity at JP Morgan and the COMEX, it's possible that some very smart money just pulled off the biggest mis-direction trade in the history of the gold market.

Stay tuned. This will be resolved soon. Gold is currently bouncing, and the bounce-back could be vicious as the rubber-band was stretched very far in one direction. If gold can not regain $1500 in the next few weeks or clear $1600 by September it may very well be done. I'm not convinced it's over and I'm sitting tight. My first physical gold was bought at $350 an ounce and I still own most of it. My mental stop is at $1,275 per ounce. If gold gets that low, I would have to reconsider my position.

What do I expect to happen? I actually expect gold to confound the mainstream "experts" once again and make new highs in 2013. This would be a massive reversal. Is there precendent? Sure there is. In 2008, gold fell 30% -- exactly the amount it has fallen from its 2011 high. It then turned around and ripped off a $1,000 rally. These things can happen in the gold market.

"Courage is being scared to death, but saddling up anyway."

-- John Wayne

Time to fess up: Yes, we're sucking wind this year -- and it hasn't been a lot of fun. Sometimes the market carries your stocks and investments upwards to the sky, and you feel like a genius, other times, it seems like every trade you make is the wrong one and the market deems you an idiot.

The latter is certainly the case at the moment with our model portfolio down 8% YTD and the S&P close to new all-time highs. I'll be honest, this doesn't make me feel good -- this is the first time in 10 years that my model portfolio has been so deeply in the red after one quarter (we have yet to have one finish the year in the red). But I'm not going to make things up and say it's okay, it's not.

But I'm also not going to panic, because panic is exactly what the market wants you to do, which is why markets often appears to shift gears just after capitulation (whether it's your personal capitulation or the general public's). The Rayno Report portfolio has been pummeled by the plunge in gold and silver and related shares. Also, energy has been surprisingly weak. I own a number of commodity names. The ferocity of the decline in the commodities complex has surprised me, but perhaps what's more surprising to me is that it has been accompanied by a rising stock market (typically plunging commodities fortell weak economic growth, and therefore are often correlated with falling stock prices; this happened in 2008).

Yes, the "Quantitative Easing" program was suppose to stoke inflation and push commodities skyward, but it hasn't, it's pushed commodities into the ground. There may be complex reasons for this but on the surface it's a paradox. My only reasonable explanation is that the situation in China is worse than thought. This is a market of many paradoxes. Below, a chart shows the extreme divergence between commodities and equities.

The S&P 500 is green, a leading commodity index is in blue. What's so strange about this is that it goes against the grain of the post-2009 recovery trade, in which these assets had been correlated by about 90%.

One of the great paradoxes of 2013: The correlation between commodities and stocks has finally decoupled.

One bright spot in our calls: We've written here regularly about the "stealth bull market" in biotech shares, which seem to go up every day. The iShares Nasdaq Biotechnology ETF is at new highs near 173, and it's up 21% year to date. Although we hold it in our model portfolio, that's not enough to overcome our worst losers such as Royal Gold (down 32%) and First Majestic Silver (40%). Shoulda bought more biotech. Shoulda coulda woulda.

That's the kind of the market in a nutshell in 2013 -- extremely powerful stocks thrusting to new highs regularly, with others simply left behind. The one observation I have about this market is that it's certainly not as easy as it looks, because many solid stocks have been left behind. One example is Intuit, a technology stock we like because of its steady growth, cash flows, and reasonable valuation. Inuit is a great company, but it's done nothing this year -- it's down 5% in the middle of a "bull market."

So what am I go to do? Absolutely nothing. The reason? April/May has been a key turning point over the years, so I'm going to watch the market closely as we glide into May. My instinct is that it's overbought and getting overvalued, and people will want to take profits going into the summer. Chances are the numbers in our portfolio will improve as the trends change. Precious metals have been so beaten up and have gotten so cheap that something has to happen -- at least a healthy short-term "dead-cat bounce." It's too late to sell them now, and with some of them no yielding over 2%, it's worth just sitting on them. It's early -- it's only April. Energy can still rally. A lot can still happen in 2013.

I would not be shocked at all to see gold and silver turn around and make new hights. To a certain extent the paradox of our portfolio is the paradox of the market -- that some stocks, such as the biotechs, march up nearly every day, but cheap, pedestrian technology stocks such as Intuit do absolutely nothing. We'll cover the paradox of the gold market in my next article.

Following my annual portfolio picks, I got some intriguing questions via email. Do you know the market will go up this year? Should I buy all of these stocks now? Should I go all in?

The answers: No, no, and no.

If I were to summarize my strategy, it would be this: If you want to reduce stress and have a reasonable chance of beating the market, you should 1) Follow a system that buys a basket of "value " with the characteristic of market-beating stocks and 2) dollar-cost average strategically over a long period of time.

In other words, I admit there is never a "perfect time to buys stocks" or "exactly the right stocks to buy." Investing isn't about betting on the sure thing -- it's about spreading out your risk and improving your odds of being slightly above average.

It's really hard -- if not impossible -- to accurately time the market. But that doesn't mean you shouldn't use timing devices! What do I mean? Well, if you think of investing as an incremental rather than a binary activity, you can use timing devices to figure out statistically opportune times to buy stocks.

The most powerful tool at an investors disposal is dollar-cost averaging, in which you deploy cash over long periods of time. This reduces the risk of going into the market at extreme highs. But if you are investing over a long period of time, wouldn't you want to use some timing devices to deploy catch at times you know might have statistically better odds of being "cheaper" times?

For example, at any given point in time during the year -- any time really -- there will be a 5% selloff. The odds are very high -- studies show this happens on average twice per year. So, if you know there is a reasonable chance of a 5% decline in the next 10 months or so, why not wait for it? If you take the long view, this means that you could use timing devices to deploy cash during moments where it is less risky to buy stocks.

What are good timing devices? There are all sorts of oscillators, sentiment indicators, and technical tools such as the put/call ratio. But I find the best tool to be sentiment indicator. I prefer to read the stock market as a barometer of emotion, if anything else. And it is quite interesting that during the course of any given year, this barometer can swing quite violently -- without really much change in economic reality. This is became humans are emotional and their perception of events is often more extreme than the impact of events themselves.

Sentiment readings are excellent indication of this human, emotional component of the market. Bullish sentiment, according to the AAII survey, recently surpassed 50%, a 12-month high, with the long run average being 40%. The low of just the past 12 months is 25%, achieved as recently as July. I find it remarkable that there can be such wide ranges of investor sentiment in such a short amount of time.

The AAII bullish readings are natural contrarian indicators. When the the crowd is feeling especially bullish, it's time to stand aside -- if not outright book some profits. If things are really bearish, it's time to add to stock positions. How do we know this? The data backs it up. See below, thanks to Thanks to Cxoadvisory.com

The chart above shows average future returns based on the AAII sentiment readings. When things are most bearish -- that is the bull reading is under 30% -- 26-week future returns are on average, much higher, more than 4%.  When things are at their most bullish -- as they are right now -- future returns average less than 2%.

To show you what a powerful contrarian tool sentiment can be in the long run, look at it this way: Bullish sentiment was 75% in January of 2000, just a month before a decade peak in the market, and it was at 19% in January of 2008, just prior to the bear market low of 2008. So clearly, extreme sentiment readings can be decent indicators of tops and bottoms.

So, if I were to use sentiment as some sort of long-term stock accumulation device, I might conclude that this really is the worst time to be accumulating stocks (even in a bull market). You want to wait for bearish AAII sentiment readings.

I can also think of it another way. What are the chances for the market to be lower at some point this year? The chances are pretty high. A decline of >=5% but less than 10% can be expected more than twice a year, according to Ned Davis Research. Such occurrences have happened more than 130 times in the last 50 years. A moderate "correction" of 10% or more can be expected about once every two years.

Now, that's the data -- the quantitative side. What about instinct? My instinct is that the market is extended and due for at least a 5% fall. This just meshes with the past action and the "feel" of the market. The market flattened out this week. and lost some momentum after a robust run. I would expect the action next week to be important -- a move to the downside could have a swift psychological effect and lead traders to book profits quickly. A fast move down to the 1425-1450 area would not be surprising.

Bottom line: I have not been adding to my portfolio. In fact, I have been selling some stocks. If I had cash I were looking at deploying into a new selection of stocks, I would wait for a better time before I started to build a position.

 

Here it is! The new Rayno Report Model portfolio for 2013. We have selected 13 stocks for 2013, in order to fight superstitious numbers with even more superstitious numbers (cheeky, eh?).

What exactly is in this portfolio? It is a collection of attractive stocks based on valuation and growth numbers. Our methodology looks for stocks that have attractive sales & profit growth relative to valuation, using forward P/E, return on equity, and growth calculations. The model likes a low P/E relative to its growth rate or Return on Equity. If the P/E is lower than its growth rate (PEG Is less than 1), excellent. If the P/E is lower than both the growth rate and the Return on Equity, fantastic! Lots of studies shows that stocks selling at a discount to growth and ROE outperform over time.

First Majestic Silver Corp. AG 20.48 2.38B 0.79 10.91 1.22 0
IAC/InterActiveCorp IACI 46.94 4.15B 1.81 12.4 0.59 2
Intuit Inc. INTU 62.22 18.42B 2.76 16.55 1.27 1.1
iShares MSCI Emerging Markets Index EEM 44.99   18.01     1.33
iShares Nasdaq Biotechnology IBB 142.62   -2.54     0.59
Lindsay Corporation LNN 81.26 1.03B 3.38 18.05 1.65 0.6
Northern Oil and Gas, Inc. NOG 17.19 1.08B 0.81 13.04 0.48 0
Omnicare Inc. OCR 37.5 4.15B 1.47 10.44 0.96 1.5
priceline.com Incorporated PCLN 648.41 32.33B 26.45 17.32 1.03 0
Riverbed Technology, Inc. RVBD 21.14 3.25B 0.42 17.31 0.99 0
Royal Gold, Inc. RGLD 79.31 5.16B 1.62 28.75 4.29 1
SeaDrill Limited SDRL 37.8 17.73B 2.12 11.86 0.6 8.8
Titan Machinery, Inc. TITN 25.75 535.93M 2.12 9.76 0.59

0

 

The bulk of our stocks are you would call "low-PEG" stocks that meet this formula. This could also be known as a "GARP" -- or Growth at a Reasonable Price strategy, though some of these stocks are priced low enought in P/E terms to be considered value investing.

To be clear, not all of the stocks this year fall into this strict valuation criteria. There are two indices -- the iShares Nasdaq Biotechnology index and the iShares MSCI Emerging Markets index -- which is a bet that those sectors will outperform. And I've included two precious metals companies (First Majestic Silver -- AG; and Royal Gold -- RGLD) because I believe that precious metals will reassert their outperformance in 2013. Precious metals companies are typically valued on reserve values, not P/E ratios. I think both these companies are attractively priced and silver seems especially poised for upside in 2013. Precious metals stocks have been unfairly punished by the market in 2013 because of the perceptions that their costs are too high, however I think rising metals prices and profitability in 2013 will show these fears to be overdone.

Overall, in running my screens and analysis for 2013, I was surprised at the number of quality high-growth companies available at reasonable valuations. IACI (Nasdaq: IACI), Priceline.com (Nasdaq: PCLN), and Omnicare (NYSE: OCR) all fall into that category. I like Riverbed (Nasdaq: RVBD) and have been looking forward to the day where it traded at a PEG of 1 or less, and that day is here. On this basis, the market does not appear overpriced. Many high-quality technology names appear quite cheap.

The energy sector is also appealing to me. Drillers have sold off, but Seadrill (Nasdaq: SDRL) has attractive profitability and growth and pays an 8% dividend. Northern Oil and Gas (NOG) is a small, fast-growing oil-shale in the Bakken region -- one of the strongest economic growth stories in the world. Go where things are happening!

In the interest of getting the portfolio out, here it is. I will profile these companies in the coming months.

(Disclosure: At the time of writing, the author and his direct family members owned many of the shares included in this model portfolio. He plans to own all of them by the end of Q1.)

Our model portfolio as reflected by the Investor Uprising Index is up 11% 2012, which is under-performing the S&P 500 index by 1% (it's up about 12% YTD). Yes there is one trading day left (today). I don't mind at all a positive double-digit year even if I under-perform the S&P 500, because I know that the model portfolio I have built is less risky than the market as whole and has done better in the long run. Personally I believe the S&P 500 is a flawed index.

As I have already mentioned, earlier in the year I left Investor Uprising, where we kept the new "IU25 Index" since 2010. That site is still up, but I will move my model portfolio back to the Rayno Report in 2013. Just a recap of the Rayno Report model portfolio strategy: When I suspended the Rayno Report Portfolio in 2010 to build the Investor Uprising site, it had a remarkable track record of 7 straight years with no losses. The model portfolio avoided the 2008 crash by being 100% in cash. The average annual return of the 7 public portfolios I published between 2004 and 2010 was a 52% annual gain.

All of this data has been transparent and published to my readers. I believe the methodology works and continues to work. The portfolio reflects not one single investing dogma, but a blend of things I've found work over time: 1) Looking for undervalued companies that appear to have been penalized by the market and 2) Spotting quality growth companies that are undervalued by the market (low-PEG stocks) and 3) Sticking with secular (long-term) trends.

My methodology is structured and refined. It is a multi-step process. I run tons of screens and look at every stock individually. I start with a bucket of about 30 ideas and reduce them to 10-12 for the year. Why do I think this formula works and it works consistently? Because it is disciplined and data-driven, it ignores the "noise" and emotion of the market. It's not driven by marketing hype or fads, which influences many of the "picks" in the media and by prominent brokers. In fact what you will find is some of the best performing stocks that have been selected by this formula were "discovered" when the market ignored them or didn't care.

Some of the best picks (with 12-month performance) have included Agrium (AGU), up 47%; Atwood Oceanics (ATW), up 12%; Celgene (Nasdaq: CELG), up 15%; Gilead Sciences (Nasdaq: GILD), up 78%; Priceline.com (Nasdaq: PCLN), up 28%, and Veeco Instruments, up 34%. All of these stocks were carefully selected after they screened for bargain valuations and my qualitative research determined that they would be good additions to the portfolio. I am still working on the list for 2012 which I plan to publish on January 6. It's okay with me that we miss a few trading days of 2013, I hope that's okay with you. There is still some more homework to do. Stay tuned: The list will be out next week.

I love it when the mainstream media goes negative on gold. That means I can buy more at a cheaper price.

This has happened again and again since the early 2000s when gold started to awake from its nearly 20-year bear market to enter a powerful bull market. We've chronicled it for you here for many years. In 2010, after an extended correction, I told you why it was going over $1,300. This bull move in gold is far from done. 

Gold has been outperforming nearly every asset class since 2000, and I don't expect this to end. The recent correction and consolidation from 2012 highs of 1,900 to a recent $1,665 is a gift.

Why? Let me boil it down: Governments around the world have had nearly a universal response the deleveraging of the global banking system -- they are printing money.

The outcome of this "reflation" strategy is that many assets have risen since 2008, when global governments brought a coordinated monetary response to the financial crisis -- but gold has risen faster. See the chart below, which shows you that since the financial crisis, stocks have merely climbed back to where they were before the crisis but the price of gold has doubled.



Because the mainstream media and many run-of-the-mill financial pundits don't like gold -- and because many of these financial pundits are short-sighted -- they have seen gold's sideways consolidation over the last 12 months as "the end" of the move. I think it's just building a platform from which to launch its biggest move ever.

Why would I have such an opinion? And why should I have conviction? My studies show that over time, gold's strongest correlation has been with money supply. Money supply growth shows no signs of abating. In fact, when the Fed ramps up its latest asset-buying program in 2013, money-supply growth is likely to accelerate. See the chart below.



The consensus is that gold has already "had its run," and that financial markets will now seek out other assets as the reflation policy is continually pursued. By I ask, if the Fed (and other world governments) are doubling down on the reflation strategy, and gold has been the primary beneficiary of this strategy over the least 10 years, why wouldn't the gold run accelerate?

The piece that gives me the ultimate conviction on this is that historically, you can calculate gold price in relation to the money supply. For many years, under the direction of Former Federal Reserve Chairman Alan Greenspan, it became fashionable to poo-poo gold's role as a currency-backing asset. But gold's recent response to money-printing has shown this is far from true. Gold is reverting to its global role as an asset backing currency bases, because people no longer trust currencies.

Here is that calculation.  US gold reserves are reported at about 8,000 tons, according to recent statistics from the World Gold Council (This, of course, doesn't address the conspiracy theorists, who say that much of this gold is gone, or has been lent out.) There are 32,000 ounces in a ton. Therefore, the US has gold reserves of about 256 million ounces. That’s about $435 billion of gold at the recent price of $1,800 per ounce. With the US currency base measure of M1 at $2.4 trillion, US gold reserves represent less than 20% of the monetary base.

Over time,  gold has traded in a range of 10% to 50% of the monetary base. Granted, this has been a volatile relationahip, but we are closer to the low end of that range than the higher end of that range. During the Great Depression in the 1930s and the inflation panic of the late 1970s, gold rose to 50% of the monetary base in pricing terms. If you assume a more reasonable rate would be an average, or mean, of 30% of the M1, then the gold price would rise to accommodate a higher share of the M1. At 30% of the M1, gold should be trading at $2,800 per ounce. The chart below shows this relationship.

But that's not all. This calculation assumes a static M1 -- but in fact the M1 is increasing. In the historical correlation, the gold price can grow two ways -- it can grow as a percentage of the currency base, or the currency base can expand. I believe both things will happen.

The last time the Federal Reserve bought $1 trillion worth of assets, the monetary base grew by $1 trillion. This should not come as a suprise, as this is the method by which the Fed creates money -- for every asset it buys from the bankingsystem it electronically creates an equal value to purchase it. For 2013, the Fed has announced it will be buying approximately $85 billion in assets per month -- for an extended period. It looks like it could buy another $1 trillion or so of assets from the banking system, so it's possible that another $1 trillion will be injected into the monetary base.

This should not be shocking, as demonstrated by the chart above. Since 2008, the monetary base has grown by $1 trillion.

If you use those numbers, then the gold price whould climb closer to $4,000 per ounce, given the relationship between gold reserves and the monetary base I outlined above.

The bottom line: I still think gold is one of the best assets to protect your wealth from monetary inflation. If the Fed is going to double down on money creation, I'm going to double down on gold.

Sorry, but no matter how much financial TV covers the fiscal cliff, I can't get worked up about it. They want me to get hysterical and panic, but my natural reaction to when the media is freaking out about something is to do the opposite.

Look at the housing bubble. Financial media discovered it after it imploded. You should have been worried about the housing bubble in 2007 when mainstream media was running features about people becoming millionaires flipping homes.

Anyway. Here's the thing about the "Fiscal Cliff" -- or FC as I will now call it. It's reality. It's like if you had a bad business that kept losing money and eventually you can't make a mortgage payment. FC is the day the sheriff comes to take possession of your home. You can think of it as an end or you can think of it as a beginning.

FC is a result of reality. "Sequestration," the name for the automatic budget cuts and tax cuts that will kick in in 2013 if Congress doesn't come up with a deal, is the fancy name for finally trying to pay your bills. The Democrats aren't real about the problem. The Republicans aren't real about the problem. The Democrats think you can raise taxes a little bit, tweak the inflation numbers in Medicare, and be alright. The Republicans think that you should implement more of the supply-side tax cuts that haven't worked in 10 years. They're both wrong. You need huge, real structural reform in government. Start by cutting the salaries of Congressmen, and go from there. Cut loopholes. Stop the mega-banks from levering up on financial derivatives. Carried interest: Acknowledge that it's just Mitt Romney's paycheck. Reform the entitlements. Get real with the American public.

And if nobody can do that? Well, welcome to austerity. I find some relief in austerity, in that at least we will no longer be living in denial. I will have less money next year. You will have less money next year. But the first step in recovery is acknowledging you have a problem.

If the FC happens, will the markets freak out? I have no idea. So far, it seems to be that there has been a fairly high probability that the FC would happen, and the markets have rallied. So maybe they know something we don't. Maybe they know that denial is bad.

This is a pretty withering market correction. Down six of seven days, with the sharp selloffs pummeling Apple as if it's suddenly become some two-bit OTC stock.

Friday's big reversal, especially in Apple Inc. (AAPL) holds some hope. To me it is the early hint that the bottom may be in. Next week will be very important because there is a big meeting of Euro finance ministers on Tuesday morning. Any sharp reversals this week will be bought by a lot of institutional investors.

You have to stand tough. Over years, I've tried to develop a psychological and statistical framework for investing that I promote here on the Rayno Report -- which requires that you ignore the emotions of the general market. Our approach is to accumulate superior stocks with a low valuations relative to their growth rate. 

If you are targetting low-PEG stocks you increase your chances of outperforming over time. It can be painful in times like this, but the point of using such a discipline is to try to take some emotion out of it. The entire point of targeting low-PEG stocks is that you are buying stocks with lower risk and this, even if you time it wrong or even buy the wrong stock (it is very hard to time the market or even buy every stock correctly), you have a statistical advantage of coming out ahead over time.

The most emotional times in the market tend to generate the worst decisions. That's my experience, anyway. It's best to ignore your emotions when you are investing in the market -- otherwise you'd be buying in January, 2000 and selling in March, 2009.  

That doesn't mean there isn't pain. I added Apple Inc. (Nasdaq: AAPL) and Cirrus Logic Inc. (Nasdaq: CRUS) after my last update, and since then there is no doubt that I've I've been creamed with these new buys. But I'm standing tough. With a forward P/E of near 8 and long and short-term cash of close to $120B, the selling in Apple is getting ridiculous.

The good news: More great stocks are getting even cheaper. ln the next few weeks I will be working up a list of great stocks at discount prices for the end of the year, which I intend to publish before January 1. So stay tuned for the new list.

In the meantime, I've picked up more biotech shares, including the IBB. The next article covers that.

I've often joked that I should have dumped everything I own into gold and biotech during the financial crisis of 2008. But it's not a joke. Both have outperformed all of the major indices by a longshot.

In the case of gold, I think there is a broadening public understanding of its outperformance and its role to protect wealth in the face of every-increasing central-bank operations. In biotech, not so much. The average Joe on the street doesn't even seem to understand the basic biotech stocks or how much innovation is occurring in the industry.

Meanwhile, the broad biotech indices are up 60% since 2008 -- before the financial crisis.

Mainstream Wall St. -- and the media -- have largely missed the great biotech bull market. Rayno Report has given you plenty of ideas though. Including this juicy biotech shopping list from July of 2010!

First of all, let's take a look at the IBB, a broad biotech index ETF. For the record, I bought the IBB yesterday, adding to a collection of stocks I've owned for many years including Celgene (CELG) and Gilead (GILD). I bought the IBB because it has pulled back a bunch and it is on my list of things I've always wanted to own more of. Here is the chart:

What a picture-perfect bull market.

Do you think that anybody that owns the IBB is complaining about the miserable decade in stocks? I didn't think so. If you are wondering what the IBB is, it's a large cap biotech index that holds many of the top biotech names such as Amgen (AMGN), Alexion (ALXN), Celgene (CELG), Biogen (BIIB), and Vertex (VRTX). It has also just undergone a big correction. So if you want more biotech exposure, this would be a place to get it.

Now let's look at the Biotech bull market compared with the S&P:

Are you kidding me? The IBB is up 60% in five years, as measured from January, 2008, before the market crash. The S&P 500, on the other hand, is still underwater -- or just about barely breakeven -- in that timeframe. That is impressive outperformance.

What's going on here? Yes, there is a bit of a momentum factor going on. Many large hedge funds have been "hiding" in biotech because with low macro-economic exposure, it has been sheltered from the global economic storm.

But there's more to it than that. Many of the individual stocks I called out here were identified as value picks in the last five years because of their relatively low price with respect to their growth rate.

My former site Investor Uprising published Guide to Biotech Investing, written by Rod Raynovich (my dad), in 2011, that told you everything about the bull market. We worked really hard on that report. We even told you what monoclonal antibodies were. It was amazing how little hype or interest there was when the report came out. People literally did not care.

That report outlined a lot of reasons for the bull market in biotech: More demand for R&D-based biotech drugs, less R&D spending and more acquisition by big pharma, more healthcare spending, and the fact that healthcare and drugs, are, in general, less susceptible to macroeconomic trends. But again, the world has just about ignored it! And still ignores it!

The bottom line: This bull market is still going strong. And I still like it. For a list of biotech stocks go see Rod Raynovich's regular biotech stock update. If you just want to cover the whole sector with an ETF, the iShares Nasdaq Biotechnology Index (IBB) or SPDR S&P Biotech (XBI) would have you covered.

(Disclosure: The author owns IBB and many individual biotech stocks included in the index, including Celgene and Gilead).

 The U.S. Election presidential election is over. Capping off one of the more partisan election seasons in memory, that means surly neighbors around the country now can exchange retorts of "I told you sos" and "go away." The simmering, partisan feuds in my own extended family have already upped the ante for potential holiday-season disaster.

Media pundits have jumped all over last week's selling, explaining it as some kind of Obama protest vote or a mini nervous breakdown about the "fiscal cliff." That's silly. First off, the sell-off was triggered by bad German economic numbers, not the U.S. election (the market actually intially rallied on an Obama victory, then sold off in the early morning hours after German industrial production numbers were released).

Secondly, if you view the election empirically, an Obama victory would be bullish, as the data is unambiguous that "the market" favors Democratic presidents. Democrat presidents have precided over better returns than Republican candidates -- by a margin 38% to 8% in inflation-adjusted returns, according to historical research (see "The U.S. Presidency and the Stock Market: A political relationshiyps study of the market performance," written by Ray Valadez and Marshall Nickles.").

So, that data clearly dispels some myth still held by media pundits that somehow a Republican victory would boost the market. Blaming Obama for a randomized set of market losses in four days of the year has few statitistical legs to stand on.

If you are a bear looking for data to support your thesis, the presidential cycle theory paints an uglier picture. Markets tend to perform poorly in the first two years of a new presidential term and better in the last two years. We just capped two year of excellent returns -- in the better half of the election cycle. The presidential election cycle theory was popularized by Stock Trader's Almanac author Jeffrey Hirsch.

The idea is this: During the 3rd and 4th year of a Presidential term, the market is likely to perform better as the incumbent introduces policies designed to stimulate the economy just in time for the election season. Note that this theory tends to work regardless of who is in power.

But focusing on these somewhat short-term data points also ignores the larger forces at work with the economy: The global deleveraging cycle. This is something that won't be solved overnight by the politicians in Washington D.C. or Brussels, but at least the early indications are that it's going okay -- at least in the United States it's not nearly the disaster that some paint it to be.

The sad loss of this past election season was that these issues were not adequately explained to the general public. The debate was framed over classical economics in the context of just another cyclical downturn: Should the respnonse be Keynesian or supply side? This is no ordinary cyclical ecomomy: It's a 50-year global credit deleveraging cycle.

Historically these have taken decades to resolve. If you're wondering why the boom years of the 1980s and 1990s felt so good compared to today's World is Flat days, the answer lies in the credit deleveraging cycle. We're now paying the price of decades of credit build-up -- and then collapse.

Look at the chart below, and you can see what credit de-leveraging -- the removal of private credit from the system -- means for the American consumer. The era of borrowing and spending is over. People are now saving and cutting back -- and have been for years. 

The private debt de-leveraging cycle is the over-ruling theme in the economy

I suppose saying this during a nationally televised Presidential election is wonkish and would not be fully understood by the Mom & Pop. "Sorry, folks, but we are deleveraging the largest shadow banking credit bubble in history -- you're going to have to wait five more years."

People don't want to wait. They want stuff now. That's our problem in a nutshell. 

The good news? According to Ray Dalio, one of the world's best hedge-fund managers, he thinks the United States is doing a decent job of deleveraging while Europe is doing miserably. This is Dalio's "Beautiful Deleverging," a combination of monetary stimulus and active reduction in bank balance sheets. You can read an interesting interview with Dalio on the topic here in Barron's. If that's not enough, he's written an entire paper detailing the "Economic Machine," and explaining how the current downturn is no ordinary cyclical downturn, but part of a a once-in-a-generation 50-year credit deleveraging.

Looking at deleveraging in the political context, private debt has been slowly reduced, but much of it has been transferred to sovereign balance sheets in order to "save" the financial system. This is what brings us our heated political debates. That can be seen in the next chart, where the public debt inflates to "fill in the hole" to meet the evaporation of private debt.

We are at an interesting juncture there, as those lines above are close to meeting. There is no doubt that the explosion of sovereign balance sheets poses great risks, but the question isn't if we need to reduce the sovereign budgets and balance sheets, it's when. Moderates such as Dalio and Jeremy Grantham argue that you need to approach the sovereign de-leveraging slowly -- while the private credit de-leveraging takes place. If you don't cushion the collapse in private sector debt with some sort of public offset -- either monetary or fiscal -- the economy would have completely collapsed. So far, the healing of the markets over the last four years has proven them right. But we're not out of the woods yet.

Yes, now that we've deleveraged banks we need to start thinking about deleveraging the government, but it's a delicate balance that can easy be thrown off track. Yes, they'll need to fix the budgets, but be careful -- global deleveraging cycles do not respond well to sharp right turns. A slow, bit-by-bit approach without any radical right or left turns makes the most sense.

In Dalio's model, you cut budgets slowly and if you raise taxes -- you raise them slowly. Meaning, you don't do what Europe did: Full-bore austerity. Meanwhile, the Fed, fully aware of the problem, is undertaking the largest monetary relation in history, attempting to push up assets with its ever-powerful printing press. This process will continue, until there is sufficient inflationary pressures in the in the system to force banks to lend again. This is why owning some gold as protection is not a bad idea. It's good insurance. It's also a reason why gold has been in one of the strongest bull markets in history.

As for the stock markets? Our markets have accurately reflected the credit-cycle deleveraging. Price/earnings ratios have been compressing for a decade. This has produced 12 years of mediocre returns to compensate for the great bull run of the 1980s and 1990s.

Is it possible we can explain this action with plain-old reversion to the mean? Yes, it is. Credit acceleration fueled economic growth and consumption for many decades. Deleveraging produces retrenchment for a typical 15 years or more. It's that simple. Democrat or Republican Presidents be damned, you can't fight the 50-year credit deleveraging. You have to embrace it.

Be patient, because we are nearing the end of one of the worst market periods in history. Develeraging will take another five years. In the meantime, as Apple Inc. has shown us, you can still find winners if you pay attention to stocks that are priced cheaply relative to their growth rate.

The recent selloff seems a bit overdone to me. With the Fed still putting its foot to the floor, you should still buy cheap stocks in this dip. Yes, by the end of this deleveraging cycle P/Es will be more compressed than ever in history. But with a disciplined approach to value stock selection, that means you are being afforded to buy stocks more cheaply than ever before, regardless of who is president.

Gold has just undergone another one of its swift and painful corrections. After bottoming in July in the $1550-$1600 range, gold vaulted $200 in just two months, nearly kissing the magic $1,800 per ounce. A reaction has followed, with gold being knocked down back toward $1,700.

This type of action is typical in the gold market, which is volatile and enigmatic (and some say controlled by nefarious sources). However, keep in mind that gold, as an asset class, is still in a strongsecular bull market. Gold has been best-performing asset class over the last decade, averaging 12% per year.

I think it will continue. It is part of the "relation regime," led by the U.S. Federal Reserve and central banks around the world as the print money to save their banking system. For this reason I still think investors need to own some gold and I think this is a buyable correction.

The first question you might ask is won't the gold bull market end? Not soon. My work shows there are major trends that support the gold bull market. Here are the biggest ones:

  • Money Supply Growth. Following the financial crisis of 2008, the U.S. Federal Reserve has followed a policy of "reflating" the economy by pushing down interest rates and increasing money supply. The price of gold has a historically high correlation with growth in the money supply. This policy is not likely to end any time soon. In fact, the continuing crisis in Europe and the advent of Quantitative Easing III (QEIII) by the Fed is likely to accelerate the trend.
  • Negative Real Interest Rates. Gold does well in an environment of negative real rates. You calculate the real interest rates by subtracting the inflation rate from the yield on the 10-year treasury note. Treasuries are yielding about 1.75%, inflation is running at an official rate of 2% but an actual rate of 3% or higher if you use other measures. So it's clear the real interest rates are negative.

I think these two trends are part of the current "Fed regime," that is the policies of the current Fed. Ben Bernanke's pledges to keep interest rates unnaturally low until 2015. His term is up in 2014. Recently threats by Mitt Romney to not keep Ben Bernanke in 2014 have contributed to the recent weakness in gold. The market fears that if Romney is elected, you will get a more  hawkish approach to interest rates.

This is crazy. The world economy is far too weak for politicians to risk jacking up interest rates now. The global banking system is still enormously fragile. They are terrified of this. They will continue to print money.

So where does that leave us with gold? Below is a three-year chart of gold futures. Gold recently sold off hard down to a Relative Strength Index (RSI) reading of near 25. When the RSI gets into the 20s, this has typically been a goold time to buy gold.

You can also see that gold has been in a large one-year consolidation pattern after its aggressive run from $1,500 to $1,900 in 2011. There is recent support near the 200-day moving average at $1,660. This consolidation has formed a "wedge" pattern which will likely be resolved by the end of the year. My expectation is that it will be resolved to the upside -- possibly in an explosive way.

 

As you know, The Rayno Report is religious about finding low-PEG stocks. Like a little child before Christmas, I get excited about finding them under the tree. Some of our low-PEG Hall of Fame stocks are Apple (Nasdaq: AAPL), Celgene (Nasaq: CELG) and Gilead Sciences (Nasdaq: GILD), low-PEGers that we found on these pages before they steadily took off like rocket ships.

What's a low-PEG stock? It's a stock that is priced by the market below its growth rate. Common wisdom is that "growth" stocks, with fast rates of profit and revenue growth, receive premium market valuation -- they have earned the right to be expensive. But what's interesting is that the market doesn't always assign a premium valuation to growth stocks. Sometimes they can be found on sale, for whatever reason: the market is skeptical of the name, the market thinks that growth will slow, there may be issues with the company, or our favorite reason -- the market is being irrational and wrong.

The reason I like the low-PEG stock strategy is that it lowers the risks you take for the potential for great rewards. Odds are, the crowd is wrong that a high-growth company should be valued below market rates. Take a look at Apple: the crowd has been proven wrong again and again.

These are the specific situations we seek: the market irrationally pricing in a cheap valuation on a quality growth name. So how is valuation "measured" and rationality assessed? Fortunately we have metrics like the price/earnings ratio and the PEG ratio. I like to define cheap or expensive in the terms of the price/earnings (P/E) ratio, which is generated by dividing the share price by the earnings per share (EPS). The PEG ratio is generated when you take the P/E ratio and divide that in turn by the earnings growth rate. Let's take an example: Let's say fictional Community Growth Corp. has a share price of $20, earnings of $2 per share, and a growth rate of 15% annual. The P/E ratio would be 10 ($20/$2) and the PEG would be .66 (10/15).

A low-PEG stock by my definition is any stock trading below a PEG of 1, meaning that it's P/E ratio is lower than its earnings growth rate. You might think by my description that low-PEG stocks are rare and hard to find. Oddly, in this market, they aren't! In fact Apple Inc. (Nasdaq: AAPL) by definition has been a low-PEG stock throughout its meteoric rise.

In fact, it seems like every time we run a stock screen of your basic Low-PEG ideas, Apple pops up.  But everybody knows Apple right? Its PEG is currently an absurd .48 -- low for what is considered basically to be the best company in the world. Why is this? I think the market discounts Apple because 1) it is so huge and 2) it's worried that at any minute one of its core franchises will come under sudden pressure 3) Highly publicized manufacturing issues with labor and quality control problems in China. Apple stock just dropped $100, trading closer to $600 than its all-time high of $700. If you think any of these issues is overdone buy the thing.

What about some new stuff?

I spent some hours on the weekend looking up some screens and scouring the charts for some interesting names. Two I like that meet my valuation criteria are Syntel Inc. (Nasdaq: SYNT) and Cirrus Logic Inc. (Nasdaq: CRUS).

Syntel is an IT outsourcer based in Troy, MI. Specialities include data warehousing and Web solutions, with a focus on the financial and healthcare sectors. Syntel has very solid numbers including annual net income of about $180 million on revenue of $708 million for an operating margin of 33%. It's got zero debt and $422 million in cash -- nearly $10 per share! With Syntel's shares recently trading hands at $61, it had a forward P/E of about 15 and a PEG of .87. Pretty good numbers for a company with mounds of cash, no debt, and large margins. I love situations like this.

Stock #2 is a little more well-known -- it's Cirrus Logic Inc. Now, Cirrus Logic is a manufacturer for Apple, so if you own Apple you need to be aware of the correlation. But like Apple and Syntel, Cirrus has great numbers. What's good about it is that with a $2.4 billion valuation, there is still a lot of room for growth. Cirrus earns about $90 million per years on $433 million in revenue, for a profit margin of about 19%. It's got a return on equity (ROE) of 20. The forward P/E is 12 and the PEG is .80. All of these are good numbers, in our book. In the last year or so the company has doubled its revenues and quadrupled its profits. I don't see any reason why it can't do that again, yielding a doubling in stock price.

Those are our stocks for the week. Let's see what the screens come up with next week -- I'll have more.

Apple cracked $700 in early September and has now pulled back sharply. It seems to me the pullback has to do with investor concerns over a possible labor strike at Foxconn, Apple's Chinese manufacturing facility.

Certainly, there should be concern. Conditions at Foxconn have been the subject of much controversy, and a plant-wide strike has the potential to shut down iPhone 5 production. But in the past, these things have passed. And they probably will again. More importantly, analysts I have spoken with say Apple could be prepping a huge fourth-quarter product push that many include not just one, but two new products.

The products would be a new iPad as well as the famous Apple TV everybody has been waiting for. If you don't think that Apple is prepping something big, you need to look at this very interesting analysis published by Horace Dediu the ASYMCO Website. Dediu demonstrates the relationship between Apple's groth in Capital Expenditures (CapEx) and revenue growth in new products. What's interesting is that CapEx is a leading indicator because Apple budgets this ahead of the production schedule, so you can see what the company is expecting.

In some shocking graphs, Dediu shows that CapEx has exploded in the just-ended quarter, to a new high of $3 billion, which is almost double what Apple has produced in the past -- just a few quarters ago. This sets the stages for a historic fourth quarter for Apple. Using historical data, Dediu attempted to project the relationship between share price and capial spending, based on what types of revenue growth has occurred in the past after CapEx jumps. According to him $1.5 billion in CapEx -- achieved just a quarter ago -- equates to a share price of $800. If history is any guide, Apple's $3 billion in CapEx would correspond to a doubling of share price from there -- to $1,600.

Of course past history is not guarantee of future results. As of this moment, the market believes a bigger concern are the working conditions in Foxconn. Will it be yet another grand buying opportunity for Apple? I have picked up some Apple shares in the $660 area on this weakness. That's a nice pullback from the all-time high of $700. Apple stock is still cheap with a P/E in the 14 range and a PEG of .63, so it's worth holding. I would no want to miss out on a possible explosion to $1,600 per share

Disclosure: Long Apple

It's been a while since we've updated the goings-on in our model portfolio, which tracks selections based on our proprietary stock-selection formula.

In 2011 I moved my stock-selection process over to www.investoruprising.com, a new Website that I built with UBM for PR Newswire. We created an index based on our stock selection system called the Investor Uprising 25 (IU25). The IU25 Index, which can be tracked in real time here, is up 32% Year-to-date (YTD)! That beats pretty much all of the major averages.

Although the index still has a short track record -- less than 24 months, the way it has behaved affirms my general strategy for picking stocks and building a portfolio -- it requires sticking to a very disciplined, long-term approach based on a value criteria. I don't necessarily buy stocks when everybody likes them, and I don't necessarily buy stocks when everybody hates them (though we try to buy more in the latter case). What I do is try to do is buy the best individual stocks with the most reasonable valuations at certain points in time.

Think of it as shopping for clothes... you want to get the best clothes at the most reaonable price. That requires going shopping often and maybe having to wait until things are on sale.

Here's how I operate my stock-selection system general: I run computer screens of the market and get a group of interesting stocks. Then I further research and analyze them until I believe I can narrow the selection down. I would describe the filtering process as such: 1) Good valuation? 2) Good growth record? 3) Good company? It's very rare that people buy stocks because of these three reasons. I believe that if you look at each particular case, you further reduce the risk in buying a stock. A great company can be available at too high a price. A stock can look cheap until you look under the hood and see the company is terribly managed and not an industry leader.

When all things come together great things can happen. An example I am most proud of is Gilead Sciences (Nasdaq: GILD), one of the IU25's core holdings, which I banged on about for many years. It is a great company, very well run. It got extraordinarily cheap, with a P/E under 10 as it traded as low as the mid-30s. People hated it in 2010. Have a look at the chart, it's very interesting! I bought it, because I believed in the company and I believed in the value. It is now one of this year's best-performing stocks with price north of $60 and just this week hit a new 52-week high.

Because this system ignores the natural bi-polar action of the market, which tends to oscillate between euphoria and panic, we are not always acquiring the trendiest and hottest stocks of the moment.

A great example of this is that we were buying gold stocks when everybody hated them. Often what we acquire are considered "dogs" -- because their valuations are cheap. For this reason, the approach requires patience. Buying mining stocks was the right thing to do, because they were cheap and they have roared back ferociously.

But conversely, we don't necessarly always buy things when they are beaten down. They can still be climbing -- as long as they are cheap relative to the growth rate. A great example of this is Apple, which has always been in our index. The reason? It's always had a very reasonable valuation -- a P/E below 12 generally -- with a high relative growth rate. Apple has historically been a cheap buy in the market.

Another great example is that a few years ago, during the 2009-2012 timeframe, my screening system was spitting out lots of drug stocks such as Merck (NYSE: MRK), Pfizer (NYSE: PFE), and Abbott Labs (NYSE: ABT). They were also paying outstanding dividends, sometimes above 5%. I bought some of these, but the process was painfully slow. These stocks were coming out of 10-year bear markets, and they flatlined for a long time before starting to climb again. But recently they have been outperforming very well.

Using such a system to outperform the market can be boring, because it is often slow, and requires patience. This is not a rapid-fire trading system. It requires trusting the system. At several points in the last year, the IU25 Index and my model portfolios were lagging, bringing out cirticism and self-doubt. But working through this and having patience is the hallmark of great investors.

All of the data on the IU25 Index, which was launched in April, 2011, can be viewed here.

Here are a few facts about the IU25 Index:

Performance, YTD: +32%

Performance, 12 months: +33%

Performance, six months: +6%

Over the last 12 months: 17 gainers, 8 losers

Two biggest gainers: Apple Inc, up 70%; Gilead Sciences, up 65%

Two biggest losers: First Solar, down 72%; Cliffs Natural, down 42%

A word about the future: There will be changes coming and I will be building a new model portfolio for 2013. The reason is that I am no longer with Investor Uprising. Going forward, I will continue to update you with stock selections and new model portfolios on the Raynoreport.com Website. Please check back for updates!

Always pay attention to new all-time highs, they are telling you something. Fertilizer producer CF Industries (NYSE: CF) has done just that this week, hitting $208 per share today, a new 52-week and all-time high.

CF has been helped by an agricultural boom, with corn and wheat prices skyrocketing from a U.S. drought, all in the face of rising global grain demand. But for anybody that dismisses this as just another commodity company is ignoring the company's incredible
track record. With a twelve-month return on equity of 39% and an operating margin of 46%, this is a finely tuned machine. There is a reason it is #1 on Barron's list of 500 best companies.</p>

The attractive numbers read like a wish-list of good investments. In addition to those great ROE and profitability numbers, CF has been growing profit and revenue at a 30% annual clip, it's got $1.7 billion on its balance sheet (with $1.6 billion in debt), and a book value of $75 per share. Operating cash flow is $2 billion per year. The company pays a .8% dividend.

I would expect that with such outstanding results you can expect the company to increase the dividend soon.

What's the key to success? In 2010, CF purchased another large fertilizer, Terra, making it the largest fertilizer producer in North America and the second largest in the world. The company has done an outstanding job of integrating those assets and strategically placing fertilizer plants all over North America, optimizing shipping routes and logistics.

The most amazing thing about CF is that it is not unusually expensive, perhaps paying the penalty that it is a commodity producer subject to the pricing swings in fertilizer. The average analyst estimate for 2012 is 26, giving it a P/E of only 7. However many analysts see earnings pulling back to $20 per share in 2013, which would give the company a P/E ratio of 10. Still not too high for a company with such high ROE and profitability numbers.

I think it's still a buy. CF fits our formula for value investing almost perfectly. Buy low-P/E. stock that have high profitability and high ROE. It's a buy and a long-term hold, and the new share-price breakout lends more confidence to the holding.

(Disclosure: I hold CF Industries in personal accounts.)

Have you noticed that mobile networks are becoming increasingly commoditized and more efficient for the consumer? Years ago, text-messaging was a value-added service, now bundles of unlimited text messages are common. And while unlimited data plans are no longer widely available, mobile bandwidth is becoming cheaper and more plentiful. The ultimate trend is that profit margins in pure connectivity and basic services are becoming tighter for mobile service providers.

Another big threat to the mobile operators is the app and social-media revolution. This puts pressure on their own messaging services, such as SMS, as users migrated to social-networking tools such as Facebook and Twitter to communicate with other users over the mobile platform.

So, as usual, mobile providers have to look for ways to diversify into new revenue streams. Clearly the app ecosystem is one place to look, although it's unclear exactly how mobile providers can profit from apps as many apps are downloaded from third parties. In the case of the Apple OS, it's Apple that controls the revenue channel -- and clearly service providers have made little headway in breaking down that relationship.

So what's next? Service providers have to look at a spate of new potential business models as the mobile device takes over the world. Here are the top contenders for new revenue-generating services in the mobile network:

  • Mobile Payments. Nearly every day I experience a "it would be nice to be able to pay with my phone" moment. We are moving in that direction. In one example, Starbucks has released an Android app that allows customers to pay with their phone. But to me, mobile payments should become pervasive -- as easy as swiping your card at the gas station. Service providers can step in providing secure ecommerce connections and taking a piece of the transaction.
  • Cloud Services Store your contacts. Back up your files. Replicate data. It's an important feature that service providers and charge a bit extra for if they do it right.
  • Mobile Health Hi-performance mobile health systems have much promise for service providers because by improving network connections and reliability, service providers could demand a premium. For example, if a patient and health-care provider require a remote-monitoring health applications, service providers could step in by providing high networking reliability and quality of service.
  • Enterprise Connectivity Services. The number-one headache for the corporate IT manager these days may be the bring your own device (BYOD) phenomenon. But this is where service providers can step in, providing outsourced management and security services. The number-one concern for enterprise managers is mobile security, which is a growing market. Service providers can step in and provide a more secur environment using tools such as Virtual Private Networks (VPNs), remote-monitoring, and anti-virus security features.

     

    I expect to see more and more news about this in the next two years, as service providers and app developers step up the pace of innovation to find new mobile business models. Below is a collection of news of just some recent developments over the last week or so:

  • Starbucks announces new mobile payment app
  • Startup adopts Qualcomm platform for remote health monitoring
  • Healthcare sector to spend $69 billion on telecom
  • Telefonica to launch European mobile security service
  • CIOs cite cloud and mobile as spending focus
  • Apple is probably the best business competitor in the world. And when you win, eventually you will have to deal with anti-trust accusations, much as Microsoft dealt with in operating systems in the 1990s. Anti-trust actions are famously difficult to prove, but I think in the coming years you'll hear more about it with Apple because it controls huge amounts of business.

    I wrote about this a couple weeks back on Investor Uprising, but I thought it would be good to summarize what about Apple makes it so dominant in the market... for, well, everything.

    Apple, after all, is not just growing in one segment. It's actually taking huge chunks of profit  out of entire industries.

    Apple also enjoys fatter profit margins because of its vertically integrated model -- which has come at the expense of telecom providers who must subsidize customers' never-ending thirst for iPhones and iPads. It also allows Apple to build in excess profits into components such as chips, because it can charge a premium.

     Let's just look at some facts about Apple's dominance.

    • Apple has single-handedly boosted the stock market. Bloomberg tells us that Apple alone has accounted for 8% of the S&P 500's rise since the 2009 bottom. And Barclay's analysts recently pointed out that Apple has had an outsized influence on the markets, accounting for 15% of the growth in all of the S&P's rise this year. They estimate Apple contributed four times its weight to the index by having outsized profits. So maybe the government should launch an inquiry into Apple controlling the stock market.

       

    • Apple's profits account for most of recent profit growth. According to FactSet research, if you subtract Apple's earnings from the market in the fourth quarter 2011, profit growth for all of the S&P 500 was -1.6%. With Apple profit growth added back in, overall profit growth was flat. That's right folks -- without Apple, there would be no growth in profits. It alone accounted for all of the profit growth in S&P 500 in the last quarter last year, and FactSet expects Apple to the be the largest source of earnings growth in Q1 2012.

       

    • Apple leverages major telecoms through subsidies. The retail price on a new iPhone can be as high as $600. A telecom carrier will sell it to you for $199. Think about Apple's core sales channel: telecom operators. Apple has so much leverage that it can largely dictate the terms in these relationships so that telecom operators subsidize sales of its devices.

      In extreme cases, such as the deal with Sprint, the subsidy is a simple transfer of wealth from carrier to Apple. Sprint tagged its subsidy expense at $1.7 billion, up from $1.2 billion a year earlier. Some analysts predict this can't last, that Apple has to give back more of its profits to carriers. But Apple's immense leverage means it can dictate the terms.

    • Apple is taking over all of retail electronics. Blog site Zero Hedge recently calculated that Apple's market capitalization now surpasses that of the entire retail industry. How is this possible? Well, as i-devices have added functionality such as music, communications, and video, they have eliminated entire segments of the industry. Maybe this is contributing to Sony's recent woes. Once you have an iPad, you need a portable DVD player?

       

    • Apple's winning the smartphone profit battle. Though it's having a see-saw battle with the Android-powered mobile phones and can't quite gain majority market share, Apple recently gained some share back and now represents 43% of the smartphone market to Android's 53%, according to the NPD group. But more importantly, Apple makes more money in this market. Keep in mind that Google does not profit on Android directly because it gives its operating system away for free to phone manufacturers, whereas Apple controls its own manufacturing from the Operating System (OS) to the memory chips. Apple's model results in more profit, because it can charge more for all of the components in its product, including the OS. Even though it's not winning top market share, Apple is winning on profitability.

       

    • Apple controls digital music. Remember the music industry? Apple's influence and control of digital music is still growing. It now accounts for 69% of all digital music sales. Amazon is a distant second with 8 percent, according to the NPD group. Apple's growth in digital sales means it now serves up about 25% of all music units, which includes physical units (even though Apple sells no physical music units), according to the NPD group. That's up from 14% in 2007.

    I think that Apple's growing power and dominance in a number of industries is likely to be a topic for trade regulators for some time. The regulators have plenty of areas to mine, most notably Apple's control of the relationships in the telecommunications sales channel.

    Will they make any progress? It may take years and years, but eventually you may see more legal action against Apple in the realm of anti-trust actions.

    Don't get me wrong: I think Apple earned the control of markets that it has. It has better products, and it's a better company. We're also not crying because Apple is one of the leading components of our IU25 Index, which is up 35% in one year.

    But it's not just about e-books. Apple's immense control now extends to the broad range of the entire business universe.

    Our screening system has delivered some great stock ideas over the years. Our screen looks for leading companies whose valuations are reasonable in relation to growth rates and Return on Equity (ROE).

    Here's an example from February 11, 2010 -- in which I said Microsoft, Apple, Sybase, and Gulfmark Offshore were buys:

    Stock Buys for the Baklava Bailout.

    Solid picks from two years ago. Sybase was bought at a 40% premium, Apple has doubled, Gulfmark is up 40%, Microsoft is up about 15% and has paid you a 3% dividend all along.

    I frequently publish these screens and send them to readers and friends. Their first instinct is to analyze every pick. "But isn't Microsoft shrinking Windows deployments?" Don't do this. The point of a screen-based portfolio is to follow the computer and ignore your more likely faulty human logic.

    Even if you have sector-specific "knowledge," it can be damaging to use it. The numbers don't lie. Often when companies are cheap it just means they are cheap, and then suddenly somebody buys them. This is exactly what happened with Sybase just three months after it made my screen.

    Look at Apple. How many people underinvested in Apple? How many people tried to over-analyze whether they could expand another market, like Pad computing? The stock has been cheap for six years. It's still cheap -- currently trading at a forward P/E of 12.

    Enough said. Here is the new screen, which I have published on Investor Uprising in our new Market Report

    Disclosure: I currently own Buffalo Wild Wings and I am looking to acquire more of these stocks over time. Positions can change at any time.

    Table 1: Our Stock Shopping LIst

    Ticker Company Name Price 2/29/2012 Market Capitalization (mil.) Forward P/E Return on Equity (%) Yield (%)
    AAPL Apple Inc. 514.85 480,031 12.108 36.6 0
    ALTR Altera Corp. 39.11 12,608 21.608 28.3 0.83
    BWLD Buffalo Wild Wings 86.38 1,586 26.335 15.9 0
    CAT Caterpillar Inc. 115 74,361 12.105 38.3 1.6
    CLF Cliffs Natural Resources, Inc. 65.47 9,298 6.749 32.16 1.76
    CMI Cummins Inc. 123.3 23,779 11.913 33.6 1.3
    HD Home Depot Inc. 46.92 72,330 16.55 20.8 2.47
    KLAC KLA-Tencor Corp. 49.06 8,180 11.681 27.25 2.88
    PCLN Priceline.com, Inc. 632.76 31,511 20.043 47 n/a
    QCOM Qualcomm Inc. 62.78 106,187 16.741 15.7 1.37
    TPX Tempur-Pedic International, Inc. 78.72 5,023 20.185 208.2 n/a
    UNH UnitedHealth Group Inc. 55.32 57,807 11.525 18.2 1.17

    Returned from CES last week. Slept for a couple days. Woke up. Tried to remember something that will change the world. Couldn't think of anything.

    Here's a problem: CES is becoming like the old Comdex. It's like a giant star that's gotten too big and general and will soon Supernova and collapse in upon itself.

    Here's another problem. Apple generates the most excitement, both form the technology and a investment perspective, in the mobile consumer electronics space. And Apple doesn't go to CES. So what you have is a gigantic hallway filled with 150,000 people trying to copy Apple.

    What's more important is what Apple will do next. Apple will do a sleeker tablet with LTE connectivity. Apple will try to do TV -- again.

    That being said, there was stuff to listen to. If you want a list of some potential future tech trends, I wrote about some futuristic stuff on Investor Uprising.

    In terms of investment ideas, I believe that the place to look in mobile and consumer is in suppliers and chips, because clearly as devices multiply it opens up many chip markets for many players. Read my CES Investor's Guide on Investor Uprising.

     

     

     

     

     

    So far our outlook has proven astute, as we advised readers to be continue to be involved in the precious metals as the best hedge in the mounting global debt crisis, which is far from over. Gold has hit a new high this week, and is likely to continue higher -- with periodic pullbacks. But this week, even more action indicates that the European debt crisis is metastisizing and likely to spread to other markets.

    The U.S. approval of a new debt ceiling has taken a back seat to some important developments in key markets.The warning signs include the following:

    * The Swiss Franc spiking to all-time highs against the dollar and other currencies

    * 30-year Treasury bond yield dropping to under 4%.

    * All European bonds being sold

    * Gold hitting new highs.

    The markets are telling you something. Personally I have gone to a much higher cash position, and I have bought more gold and silver as protection against mounting currency devaluation. I also believe there are certain places to hide such as high-yielding energy, dividend, and biotech stocks. 

    As a reminder, in March, Investor Uprising launched a premium investment newsletter service that gives you access to our best ideas and detailed research. Investor Uprising Confidential (IU Confidential) published an important report, "All That Glitters: The Ultimate Gold Report," which told you why at $1,450 gold was still undervalued and likely to go much higher. Gold traded today as high as $1,646.The report tells you why this is likely to be only a way-station to much higher prices.

    IU Confidential also completed some detailed research on the Biotech market, which shows that it can be a "place to hide." The biotech market, as measured by leading biotech indices, did not lose as much during the 2008 financial crisis -- and when it bounced back, the performance was much better than the leading indices. In other words, Biotech has outperformed the S&P 500 with less risk during the last five years.

    Our research indicates this is likely to continue. You can still get both of these reports individually -- or subscribe to the service and get both of them plus five more bi-monthly reports for the next 12 months.

    As a Rayno Report reader, this research is available to you at an exclusive low price. Click below for these exciting offers:

    The Best of Biotech -- $399 Special (Regular $500)

    The Ultimate Gold Report -- $299 Special (Regular $500)

    Full Annual Subscription: IU Confidential Annual Subscription

    (Includes The Ultimate Gold report, Best of Biotech Report + 5 more reports over the next 12 months!) -- $999 Special (regular $1250.

    I have become fascinated by Acai, even though I can still not pronounce it correctly and I won't even bother trying to figure out how to print it with the accent which I can't find on my computer keyboard. I'm an admitted latecomer to the trend. Yes, it's old news. But it's still a good story. The recent New Yorker article did a great job outlining the background.

    The New Yorker article tells the tale of how two SoCal chums and University of Colorado grads (Go Buffs!) Ryan and Jeremy Black "discovered" acai in the Braizilian jungle and started marketing it in the United States, kicking off what would become one of the most potent health-food marketing booms in recent history, aided and abetted by none other than Oprah.

    What I found interesting about the article is not so much about the controversy surrounding the health benefits of acai (like most debates, the truth lies probably somewhere in between), but the entrepreneurial spirit of the two Black brothers and their partner Edmund Nichols. The went to the jungle with a load of credit-card debt, locked in a long-term contract to sell acai through a Brazilian producer, and spent hundreds of thousands in the first year to ship Acai to the United States. Within two years they were doing half a million in sales and now they do $50 million. Quite an adventure.

    The other story in acai is about marketing. How does an obscure jungle fruit go from being a locally enjoyed delicacy to a multi-billion-dollar global business in ten years? Savvy marketing. The blacks hooked into real-world health research and captured the Brazilian mystique. The more nefarious marketeers later leveraged Acai into online marketing scams. But both the legitimate companies and online scammers had something in common: They knew that consumers like a good story, and you can't get much better of a story than a mysterious berry coming out of the Brazilian jungle.

    Here is an abstract of the article from the New Yorker (full article available only in print):

    ABSTRACT: DEPT. OF FOOD about açaí. Açaí was virtually unknown outside Brazil until ten years ago, when Ryan and Jeremy Black, two brothers from Southern California, and their friend Edmund Nichols began exporting it to America. Embraced as a “superfruit”—a potent mix of cholesterol-reducing fats and anti-aging antioxidants—açaí became one of the fastest-growing foods in history. Supermarkets have become filled with açaí-laced products. Lately, however, studies have questioned the extravagant health claims for açaí, and online vendors selling diluted products have raised the question of whether açaí is a fraud. Early boosters like Oprah Winfrey and Dr. Mehmet Oz sued to remove their names from the marketing, and the Federal Trade Commission shut down the operations of a major Internet açaí seller.

    Read more http://www.newyorker.com/reporting/2011/05/30/110530fa_fact_colapinto#ixzz1OKFfI9Ay

    It's hard to pick stocks in cloud computing, because so many of them have become absurdly overvalued. So what I do is look at a handful of them, learn about the companies, and try to figure out which ones have true staying power. Then you look for opportunities to buy them on pullbacks.

    Riverbed is a company that I have been following for several years. I have published a profile of Riverbed here on my new site, Investor Uprising, in which I try to explain how Riverbed plans to expand. A true "best of breed" player in WAN optimization, Riverbed is now looking to use its leverage in that market to branch out and grow on more fronts. I had a chance to meet with several Riverbed executives at Interop in Las Vegas, and following those meetings I think the company is on the verge of taking it to the next nevel. CEO Jerry Kennelly very clearly described some growth opportunities for the company that will take it from a point-product company to a multifaceted networking power.

    Here's the important thing about Riverbed: Its technology takes advantages of long-term trends in networking in computing: Data-center consoldiation, the migration of apps from the enterprise to the cloud, and outsourced networking optimization. If you are asking what this all means because it's too many buzzwords -- it's that large and small companies both are looking to outsource more of their technology and networking needs to service providers who operate in the "cloud" -- providing any application or computing online, at any time.

    The reason this is important for Riverbed is because it flies in the face of what has built the existing networking juggernaut: Cisco Systems. Cisco is built on the emergence of Ethernet networks and IP routing. It comes from an era in which companies hired armies of IT people to configure and deploy Ethernet switches and routers. All of that is moving to the cloud and massive data centers run by service providers. The interesting thing here is that Cisco has displayed weakness in selling data-center products: Its software is aging and lacks the scale to handle the shift.

    This is a profound shift and one to carefully watch in the networking space. On the valuation, Riverbed recently pulled back $10 from an all-time high and I used the opportunity to pick up some shares. The P/E is a palatable 30, given a growth rate in excess of 40%. The PEG is now 1.40, which is well of recent highs. You have to pay up for this company because it has such huge prospects.

    (Disclosure: Long RVBD).

    Another Fed day, another episode of serial money printing, another banner day and a new high for gold.

    It really feels like gold has entered the final and most exciting stage of the bull market. As Jim Sinclair, long-term gold trader, Chairman of Tanzanian Royalty Exploration, and Publisher of JSMineset.com says, gold is ready to go ballistic.

    It's another breakout in a series of powerful breakouts. We've been alerting you to these breakouts ever since this site was launched. Remember this one? Or what about this one?  And this one.

    It seems to happen at least twice a year now, gold consolidates for about six months and then breaks out into a powerful $200 move. But silver is now the star, having doubled in less than a year!

    Here's some good reading on the topic:

     

    Investment comrades, I have helped launched a new site sponsored by PRNewswire called investor Uprising. There, you will find everything you love to follow, including business trends, rising companies, stock picks, and model portfolios.

    The Guide to Investment Metrics tells you how to screen for more reasonably valued companies. Investor Uprising expands on the investment philosophy developed in these pages: looking for reasonably valued, growing companies and invest slowly over time, ignoring volatile market swings and focusing on dollar-cost averaging. It works in bull markets, and it helps you survive in bear markets. By focusing on stocks with low valuations, you can reduce your risk.

    Go to the site now and register  -- if you are among the first 1,000 registrants you will be entered into a drawing for a free iPad!

    Check it out here.

    Next week I am launching a new Website for PRNewswire called Investor Uprising. It is going to focus on high-quality investment opportunities and business trends. We'll also pick and watch lots of stocks on a GARP (Growth at a Reasonable Price) basis.

    For the first project, we are creating a list of 30 companies which we will use to build an Index. This comes from a methodology I have used for 10 years to screen stocks and build "monkey" portfolios that can be bought and passively left alone. Using this method, the portfolios have averaged a 30% (cumulative) return since 2006 and none of them has ever lost money.

    Next week you will find these stock picks on Investor Uprising (which has not yet launched), but today I'm going to give you four of them. Here are some low-PEG stocks we will be following at Investor Uprising.

    Dolby Laboratories (DLB)

     12-month sales growth: 28%

    12-month income growth: 17%

    Forward P/E: 15

    Return on Equity: 20%

    PEG Ratio: 1

    Summary: Dolby is dominating the business for digital music tools. Specifically, it licenses many of the leading digital sound and signal processing systems for digital film, DVS, Blu-ray, and digital 3D systems. It has been steadily growing for years.

    Veeco Instruments Inc. (VECO)

     12-month sales growth: 150%

    12-month income growth: 1,000%

    Forward P/E: 13

    Return on Equity: 46%

    PEG Ratio: .72

    Qualitative: Veeco is a leading manufacturer of important manufacturing and testing equipment in the LED, solar, and seminconductor market. It also makes equipment for the manufacturing of disk drives. If Veeco's growth rates seem absnormally hight, its because it swung from losses to a profit in 2010, yielding what looks like spectacular earnings growth. It has also growth its revenue through merger.

    Gilead Sciences Inc. (GILD)

     12-month sales growth: 0%

    12-month income growth: -20%

    Forward P/E: 9

    Return on Equity: 45%

    PEG Ratio: .70

    Qualitative: Gilead is an extremely well-managed biotech company with a long track record of high ROE. Recently, it's revenues have been flat and earnings have shrunk due to maturity of some key drug markets. However, it is still enormously profitable, booking $2.9B in profits in 2010, and its valuation is just plain cheap.

    Medifast Inc. (MED)

    12-month sales growth: 57%

    12-month income growth: 147%

    Forward P/E: 10

    Return on Equity: 33%

    PEG Ratio: .50

    Qualitative: Medifast is a fast-growing producer of diet supplements and nutrition products. The Medifast brands include many varieties of diet and weight-loss shakes, vitamins, food bars, and other food products.

    Stay tuned for the launch of the new site! We are looking for moderators and bloggers. If you are interested, ping me at scott.raynovich@investoruprising.com.